Rios Israel 4
4 · SCICLONE PHARMACEUTICALS INC · Filed Mar 14, 2012
Insider Transaction Report
Form 4
Rios Israel
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2012-03-13$1.08/sh+48,750$52,650→ 73,750 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2012-03-13−48,750→ 16,250 totalExercise: $1.08Exp: 2019-03-06→ Common Stock (48,750 underlying)
Footnotes (2)
- [F1]Granted under the Issuer's 2005 Equity Incentive Plan.
- [F2]25% of such shares vest one year from the date of grant, of March 6, 2009, and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer.